Drug class
Non-steroidal anti-inflammatory drug (NSAID); pyrazolidinedione derivative
Mechanism of action
Inhibits cyclo-oxygenase-mediated prostaglandin synthesis, reducing inflammatory mediators and producing anti-inflammatory, analgesic and antipyretic effects. This is a class-level pharmacological description; exact clinical use is restricted by species and product authorisation.
General use cases
- Veterinary use: relief of inflammatory conditions associated with the musculoskeletal system in dogs and horses under applicable veterinary authorisations. Certain equine oral formulations are not for use in horses intended for human consumption. It is not a general human therapeutic indication.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
